Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Jul;40(7):1715–1716. doi: 10.1128/aac.40.7.1715

Effect of combination therapy with ciprofloxacin and clarithromycin on theophylline pharmacokinetics in healthy volunteers.

J G Gillum 1, D S Israel 1, R B Scott 1, M W Climo 1, R E Polk 1
PMCID: PMC163401  PMID: 8807068

Abstract

Five adults completed this four-way randomized crossover study to compare the effects of oral treatment with ciprofloxacin, clarithromycin, and a combination of the two drugs on theophylline pharmacokinetics. The area under the concentration-time curve for theophylline during combination therapy was not different from that for ciprofloxacin alone. Beta error may explain this finding, but any real effect from combination treatment appears to be clinically unimportant.

Full Text

The Full Text of this article is available as a PDF (187.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fuhr U., Anders E. M., Mahr G., Sörgel F., Staib A. H. Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro. Antimicrob Agents Chemother. 1992 May;36(5):942–948. doi: 10.1128/aac.36.5.942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gu L., Gonzalez F. J., Kalow W., Tang B. K. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1. Pharmacogenetics. 1992 Apr;2(2):73–77. doi: 10.1097/00008571-199204000-00004. [DOI] [PubMed] [Google Scholar]
  3. Ha H. R., Chen J., Freiburghaus A. U., Follath F. Metabolism of theophylline by cDNA-expressed human cytochromes P-450. Br J Clin Pharmacol. 1995 Mar;39(3):321–326. doi: 10.1111/j.1365-2125.1995.tb04455.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hendeles L., Jenkins J., Temple R. Revised FDA labeling guideline for theophylline oral dosage forms. Pharmacotherapy. 1995 Jul-Aug;15(4):409–427. [PubMed] [Google Scholar]
  5. Parent M., LeBel M. Meta-analysis of quinolone-theophylline interactions. DICP. 1991 Feb;25(2):191–194. [PubMed] [Google Scholar]
  6. Periti P., Mazzei T., Mini E., Novelli A. Pharmacokinetic drug interactions of macrolides. Clin Pharmacokinet. 1992 Aug;23(2):106–131. doi: 10.2165/00003088-199223020-00004. [DOI] [PubMed] [Google Scholar]
  7. Rieder M. J., Spino M. The theophylline-erythromycin interaction. J Asthma. 1988;25(4):195–204. doi: 10.3109/02770908809071366. [DOI] [PubMed] [Google Scholar]
  8. Rockwood R. P., Embardo L. S. Theophylline, ciprofloxacin, erythromycin: a potentially harmful regimen. Ann Pharmacother. 1993 May;27(5):651–652. doi: 10.1177/106002809302700523. [DOI] [PubMed] [Google Scholar]
  9. Sarkar M. A., Hunt C., Guzelian P. S., Karnes H. T. Characterization of human liver cytochromes P-450 involved in theophylline metabolism. Drug Metab Dispos. 1992 Jan-Feb;20(1):31–37. [PubMed] [Google Scholar]
  10. Tröger U., Meyer F. P. Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation. Clin Pharmacokinet. 1995 Apr;28(4):287–314. doi: 10.2165/00003088-199528040-00003. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES